AAFPRS President Addresses Concerns About Moderna COVID-19 Vaccine
AAFPRS will continue monitoring reports of incidents of reactions in patients with dermal fillers who received the Moderna COVID-19 vaccine.
AAFPRS will continue monitoring reports of incidents of reactions in patients with dermal fillers who received the Moderna COVID-19 vaccine.
Lumenis has introduced triLIFT 2.0, a new platform that combines muscle stimulation and skin treatment technologies to address facial and body aging by targeting both underlying muscle structure and dermal quality.